these approaches to build companies since he parlayed a $50,000 investment in
struggling KeyPharmaceuticals Inc. in 1972 into an $825 million sale to Schering-Plough 14
years later ... drug approved. We had a natural, great mix."
The pair bought KeyPharmaceuticals, boosting Key's sales via asthma drug Theo-Dur and
cardiovascular patch Nitro-Dur. Frost switched gears